Equities Analysts Set Expectations for BIOX Q2 Earnings

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Analysts at Brookline Capital Management reduced their Q2 2025 EPS estimates for Bioceres Crop Solutions in a research report issued to clients and investors on Tuesday, November 12th. Brookline Capital Management analyst K. Dolliver now anticipates that the company will post earnings of $0.14 per share for the quarter, down from their previous forecast of $0.28. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.33 per share. Brookline Capital Management also issued estimates for Bioceres Crop Solutions’ Q3 2025 earnings at $0.02 EPS and FY2025 earnings at $0.16 EPS.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. The company had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. During the same period in the prior year, the company earned ($0.07) earnings per share.

BIOX has been the subject of a number of other research reports. Canaccord Genuity Group raised Bioceres Crop Solutions to a “strong-buy” rating in a report on Friday, July 19th. Lake Street Capital dropped their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating for the company in a research note on Wednesday, September 11th. Oppenheimer decreased their target price on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research report on Monday, October 21st. Roth Mkm dropped their price target on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating for the company in a research report on Wednesday, September 11th. Finally, Canaccord Genuity Group cut their price target on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research note on Wednesday. Four equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $12.13.

Bioceres Crop Solutions Stock Performance

NASDAQ:BIOX opened at $6.17 on Friday. The stock has a 50 day simple moving average of $7.58 and a 200 day simple moving average of $9.80. The stock has a market cap of $387.78 million, a P/E ratio of 321.16 and a beta of 0.49. Bioceres Crop Solutions has a 1-year low of $5.71 and a 1-year high of $14.05. The company has a current ratio of 1.27, a quick ratio of 0.86 and a debt-to-equity ratio of 0.37.

Hedge Funds Weigh In On Bioceres Crop Solutions

Hedge funds have recently bought and sold shares of the company. Fourth Sail Capital LP lifted its holdings in shares of Bioceres Crop Solutions by 61.6% during the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock worth $24,957,000 after acquiring an additional 1,209,277 shares during the period. Long Focus Capital Management LLC boosted its holdings in shares of Bioceres Crop Solutions by 19.9% in the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock valued at $3,145,000 after purchasing an additional 46,647 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. acquired a new stake in shares of Bioceres Crop Solutions in the 2nd quarter valued at $472,000. Ping Capital Management Inc. bought a new position in shares of Bioceres Crop Solutions in the 2nd quarter valued at $448,000. Finally, Lazard Asset Management LLC acquired a new position in shares of Bioceres Crop Solutions during the 1st quarter worth $212,000. 17.68% of the stock is owned by institutional investors.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.